The Impact of the COVID-19 Omicron Variant on Immunocompromised Patients: ICU Admissions and Increased Mortality
Abstract Introduction The corona virus disease 19 (COVID-19) pandemic has presented a global health challenge, and several consecutive variants of the severe acute respiratory syndrome–corona virus-2 (SARS-CoV-2) virus have been dominant. Previous studies highlighted decreased mortality rates during...
Saved in:
| Main Authors: | Jan Pander, Fabian Termorshuizen, Dylan W. de Lange, Wendy Beekman-Hendriks, Josien Lanfermeijer, Ferishta Bakhshi-Raiez, Dave A. Dongelmans |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-03-01
|
| Series: | Infectious Diseases and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40121-025-01122-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patient
by: Ignacio Garcia, et al.
Published: (2024-10-01) -
The Outcome of BA.5 Omicron in Transplant Cases: A Retrospective Single-center Study in Jeddah Saudi Arabia
by: Mona A. Bahasan, et al.
Published: (2025-01-01) -
Clinical characteristics of SARS-CoV-2 Omicron pneumonia in immunocompromised and immunocompetent patients: A retrospective cohort study
by: Xiaoyan Li, et al.
Published: (2024-10-01) -
Harnessing the microbiome to improve clinical outcomes for cancer, transplant, and immunocompromised patients in the intensive care unit (ICU)
by: Lizbeth Nieves, et al.
Published: (2025-06-01) -
Pulmonary tuberculosis in the immunocompromised patients
by: Vukosav Danijela, et al.
Published: (2019-01-01)